DHL Expands Final-Mile Capabilities with SDS Rx Acquisition
DHL Supply Chain has completed its acquisition of SDS Rx, a U.S.-based provider of final-mile delivery and healthcare transportation services. The move strengthens DHL’s position in the life sciences and healthcare logistics sector by integrating SDS Rx’s 200-plus locations into its existing network. Operations will continue under local leadership while integration efforts aim to maintain service quality and expand capabilities.
DHL CEO Mark Kunar emphasized that the acquisition will improve the company’s ability to serve healthcare providers and patients with better precision and care.
The deal was first announced in September.
Though typically the shortest leg in the journey, final-mile delivery can account for large shipping costs due to challenges like multiple stops, traffic, and unpredictability. Through this acquisition, DHL is integrating a dense U.S. final-mile system network into its global logistics system.
About the Author
Daniel BeairdDaniel Beaird
Head of Content and Editor-in-Chief
Daniel Beaird is Head of Content and Editor-in-Chief of Healthcare Purchasing News (HPN), where he leads editorial strategy and content development across print, digital, podcasts, webinars, and educational programming. His coverage focuses on healthcare supply chain, sterile processing, infection prevention, and perioperative services, connecting industry developments with the purchasing and operational decisions that shape patient care.
Before joining HPN, he served as Senior Editor of The Journal of Healthcare Contracting, covering health system supply chain strategy, industry partnerships and the evolving business of healthcare.
He holds a bachelor’s degree in journalism from the University of Georgia and is based in Atlanta.
Related
dhl